Gyorgy Keri
Affiliations: | Semmelweis Egyetem, Hungary |
Area:
Molecular Biology, PharmacyGoogle:
"Gyorgy Keri"Children
Sign in to add trainee| Daniel Eros | grad student | 2005 | Semmelweis Egyetem |
| Zsolt Szekelyhidi | grad student | 2005 | Semmelweis Egyetem |
| Gabor Borbely | grad student | 2012 | Semmelweis Egyetem |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Szőke É, Bálint M, Hetényi C, et al. (2020) Small molecule somatostatin receptor subtype 4 (sst) agonists are novel anti-inflammatory and analgesic drug candidates. Neuropharmacology. 178: 108198 |
| Zsákai L, Sipos A, Dobos J, et al. (2019) Targeted drug combination therapy design based on driver genes. Oncotarget. 10: 5255-5266 |
| Artarini A, Meyer M, Shin YJ, et al. (2019) Regulation of influenza a virus mRNA splicing by CLK1. Antiviral Research |
| Brauswetter D, Gurbi B, Varga A, et al. (2017) Molecular subtype specific efficacy of MEK inhibitors in pancreatic cancers. Plos One. 12: e0185687 |
| Brägelmann J, Dammert MA, Dietlein F, et al. (2017) Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma. Cell Reports. 20: 2833-2845 |
| Ekins S, Godbole AA, Kéri G, et al. (2017) Machine learning and docking models for Mycobacterium tuberculosis topoisomerase I. Tuberculosis (Edinburgh, Scotland). 103: 52-60 |
| Singh V, Donini S, Pacitto A, et al. (2016) The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis. Acs Infectious Diseases |
| Murányi J, Gyulavári P, Varga A, et al. (2016) Synthesis, characterization and systematic comparison of FITC-labelled GnRH-I, -II and -III analogues on various tumour cells. Journal of Peptide Science : An Official Publication of the European Peptide Society. 22: 552-60 |
| Booij TH, Klop MJ, Yan K, et al. (2016) Development of a 3D Tissue Culture-Based High-Content Screening Platform That Uses Phenotypic Profiling to Discriminate Selective Inhibitors of Receptor Tyrosine Kinases. Journal of Biomolecular Screening |
| Garamvölgyi R, Dobos J, Sipos A, et al. (2016) Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells. European Journal of Medicinal Chemistry. 108: 623-43 |